In order to evaluate the potential of DPP4 as a therapeutic target in BA, we further aimed to investigate the enzymatic DPP4 activity in infants with BA and DPP4 activity regulation in experimental BA by studying the effect of DPP4 inhibition on cytokine production and the clinical course of experimental BA. This evidence concerns the gene DPP4 and breast angiosarcoma.